Bioqube Ventures
Investor profile
Venture capital
Bioqube Ventures has backed 3 European tech companies across 3 funding rounds between 2022 and 2023, joining rounds totalling €36M. Most active in Healthtech and Deeptech. Data as of 4 Nov 2026.
Deals
3
distinct rounds
Companies
3
backed
Active span
2022–2023
2 yrs
Total round €
€36M
sum of rounds joined
Deals by year
distinct rounds / yearBioqube Ventures — deals by year — interactive chart.
Data table
| Bioqube Ventures — deals by year | |
|---|---|
| 2022 | 2 |
| 2023 | 1 |
Top sectors
by dealsBioqube Ventures — top sectors — interactive chart.
Data table
| Bioqube Ventures — top sectors | |
|---|---|
| Healthtech | 2 |
| Deeptech | 1 |
Stages
by dealsBioqube Ventures — stages — interactive chart.
Data table
| Bioqube Ventures — stages | |
|---|---|
| Other | 1 |
| Seed | 1 |
| Series A | 1 |
Countries
by dealsBioqube Ventures — countries — interactive chart.
Data table
| Bioqube Ventures — countries | |
|---|---|
| France | 1 |
| Netherlands | 1 |
| UK | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared roundsPortfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Tridek-One | France | 1 | €16M |
| Enhanc3D Genomics | UK | 1 | €11M |
| Anavo Therapeutics | Netherlands | 1 | €8.5M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Tridek-One | Other | €16M | 2022-09 |
| Enhanc3D Genomics | Series A | €11M | 2022-10 |
| Anavo Therapeutics | Seed | €8.5M | 2023-05 |